TCI Wealth Advisors’s Bionano Genomics BNGO Stock Holding History

TCI Wealth Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3	Closed	-$2.22K	–	476
2023 Q1	$2.22K	Hold	3	–	–	﹤0.01%	1941
2022 Q4	$2.77K	Hold	3	–	–	﹤0.01%	1891
2022 Q3	$3K	Hold	3	–	–	﹤0.01%	1732
2022 Q2	$3K	Hold	3	–	–	﹤0.01%	1759
2022 Q1	$5K	Sell	3 -1	-25%	-$1.35K	﹤0.01%	1505
2021 Q4	$7K	Buy	4 +1	+33%	+$2.67K	﹤0.01%	1403
2021 Q3	$11K	Hold	3	–	–	﹤0.01%	1017
2021 Q2	$12K	Buy	3 +1	+50%	+$3.95K	﹤0.01%	838
2021 Q1	$11K	Buy	+2	New	+$11.3K	﹤0.01%	798

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCI Wealth Advisors's BNGO Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 3 shares — an estimated $2.22K sold.

TCI Wealth Advisors first reported a position in BNGO in Q1 2021 and held it in 9 quarters. The position peaked at $12K in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

TCI Wealth Advisors reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 3 Bionano Genomics shares in Q2 2023, an estimated $2.22K.
TCI Wealth Advisors first reported a position in Bionano Genomics in Q1 2021 and held it in 9 quarters.
TCI Wealth Advisors's Bionano Genomics position peaked at $12K in Q2 2021.
108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.